Routine stress testing in diabetic patients after percutaneous coronary intervention: the POST-PCI trial

Diabetes is a common comorbidity among patients with chronic or acute coronary syndrome, and patients with diabetes have a more aggressive form of atherosclerosis and more extensive coronary artery disease (CAD).1,2 In addition, diabetes is a major determinant of adverse clinical events after myocardial revascularization.3,4 In daily clinical practice, patients with diabetes frequently undergo percutaneous coronary intervention (PCI), with these procedures often being more complex and anatomically challenging.

Click here to continue reading:

Παλαιότερα άρθρα